Aquestive Therapeutics
AQST
HK$22.31
Share price
-5.59%
Change (1 day)
-34.93%
Change (1 year)
Categories
Revenue for Aquestive Therapeutics (AQST)
Revenue in 2024 (TTM): HK$0.44 Billion
According to Aquestive Therapeutics
's latest financial reports the company's current revenue (TTM 
) is HK$0.44 Billion. an increase over the revenue in the year 2023 that were of HK$0.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Aquestive Therapeutics from 2017 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | HK$0.44 B | 13.12% |
| 2023 | HK$0.39 B | 6.05% |
| 2022 | HK$0.37 B | -6.01% |
| 2021 | HK$0.39 B | 11.52% |
| 2020 | HK$0.35 B | -13.25% |
| 2019 | HK$0.40 B | -22.41% |
| 2018 | HK$0.52 B | 1% |
| 2017 | HK$0.52 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | HK$1.75 M | -99.61% | 🇺🇸 USA |
 | HK$5.54 B | 1,138.93% | 🇺🇸 USA |